SK134395A3 - Transdermal therapeutical agent and preparation method thereof - Google Patents

Transdermal therapeutical agent and preparation method thereof Download PDF

Info

Publication number
SK134395A3
SK134395A3 SK1343-95A SK134395A SK134395A3 SK 134395 A3 SK134395 A3 SK 134395A3 SK 134395 A SK134395 A SK 134395A SK 134395 A3 SK134395 A3 SK 134395A3
Authority
SK
Slovakia
Prior art keywords
pilocarpine
transdermal therapeutic
transdermal
therapeutic agent
weight
Prior art date
Application number
SK1343-95A
Other languages
English (en)
Slovak (sk)
Inventor
Lothar Deurer
Karlheinz Otto
Thomas Hille
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of SK134395A3 publication Critical patent/SK134395A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1343-95A 1993-04-28 1994-04-25 Transdermal therapeutical agent and preparation method thereof SK134395A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4313928A DE4313928C2 (de) 1993-04-28 1993-04-28 Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
PCT/EP1994/001281 WO1994025025A2 (de) 1993-04-28 1994-04-25 Systeme zur kontrollierten abgabe von pilocarpin

Publications (1)

Publication Number Publication Date
SK134395A3 true SK134395A3 (en) 1997-02-05

Family

ID=6486612

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1343-95A SK134395A3 (en) 1993-04-28 1994-04-25 Transdermal therapeutical agent and preparation method thereof

Country Status (19)

Country Link
US (1) US5869086A (sh)
EP (1) EP0695182A1 (sh)
JP (1) JPH08509716A (sh)
KR (1) KR960702308A (sh)
AU (1) AU694115B2 (sh)
CA (1) CA2161520A1 (sh)
CZ (1) CZ277995A3 (sh)
DE (1) DE4313928C2 (sh)
FI (1) FI955161A (sh)
HR (1) HRP940270A2 (sh)
HU (1) HU220045B (sh)
IL (1) IL109340A (sh)
NO (1) NO309174B1 (sh)
NZ (1) NZ265950A (sh)
PL (1) PL175077B1 (sh)
SK (1) SK134395A3 (sh)
WO (1) WO1994025025A2 (sh)
YU (1) YU22894A (sh)
ZA (1) ZA942874B (sh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung
AU719171B2 (en) * 1995-01-14 2000-05-04 Abbott Laboratories A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
EP1221315A4 (en) * 1999-10-13 2007-12-12 Senju Pharma Co ADHESIVE OPHTHALMIC PREPARATIONS FOR PERCUTANEOUS SPREADING
DE10246503A1 (de) * 2002-03-26 2003-10-16 Tesa Ag Verwendung von Haftklebemassen für medizinische Verklebungen
JP4629578B2 (ja) 2003-01-22 2011-02-09 ニチバン株式会社 眼疾患治療用経皮吸収型製剤
DE602005019724D1 (de) * 2004-05-21 2010-04-15 Senju Pharma Co Ophthalmologische perkutan absorbierbare zubereitung enthaltend einen muscarin-rezeptor-agonist
CN101123948A (zh) * 2005-02-17 2008-02-13 千寿制药株式会社 眼科用固体外用药剂
KR20080031430A (ko) * 2005-07-26 2008-04-08 센주 세이야꾸 가부시키가이샤 경피적으로 흡수가능한 안과용 제제
US20100323978A1 (en) * 2009-06-22 2010-12-23 Calvin Hanna Non-aqueous oil delivery system for ophthalmic drugs
EP2606895A4 (en) * 2010-10-12 2014-04-02 Univ Wuhan TRANSDERMAL ABSORPTION STAMP OF ANTIVIRAL DRUG AND METHOD FOR PREPARING THE SAME
KR101688061B1 (ko) 2014-10-06 2017-01-02 주식회사한국파마 필로카르핀 경피 흡수 제제
JP6526475B2 (ja) * 2015-04-30 2019-06-05 サンスター株式会社 経皮唾液腺投与用の唾液分泌促進剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4713244A (en) * 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US5273757A (en) * 1987-09-01 1993-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Apparatus for the delivery of substances, processes for the production thereof and use thereof
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5021053A (en) * 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
EP0537165B1 (en) * 1990-04-27 1998-07-01 Allergan, Inc. Polymeric drug delivery system

Also Published As

Publication number Publication date
FI955161A (fi) 1995-11-24
IL109340A0 (en) 1994-07-31
IL109340A (en) 1998-10-30
NO954325L (no) 1995-10-30
NZ265950A (en) 1997-08-22
AU6648194A (en) 1994-11-21
JPH08509716A (ja) 1996-10-15
PL311281A1 (en) 1996-02-05
KR960702308A (ko) 1996-04-27
NO309174B1 (no) 2000-12-27
WO1994025025A3 (de) 1995-03-02
HU220045B (hu) 2001-10-28
DE4313928A1 (de) 1994-11-03
NO954325D0 (no) 1995-10-27
HU9503087D0 (en) 1995-12-28
FI955161A0 (fi) 1995-10-27
WO1994025025A2 (de) 1994-11-10
HUT75029A (en) 1997-03-28
HRP940270A2 (en) 1996-08-31
US5869086A (en) 1999-02-09
CA2161520A1 (en) 1994-11-10
AU694115B2 (en) 1998-07-16
PL175077B1 (pl) 1998-10-30
YU22894A (sh) 1997-08-22
CZ277995A3 (en) 1996-05-15
EP0695182A1 (de) 1996-02-07
DE4313928C2 (de) 1996-09-19
ZA942874B (en) 1995-07-06

Similar Documents

Publication Publication Date Title
JP4629578B2 (ja) 眼疾患治療用経皮吸収型製剤
JP5020061B2 (ja) 経皮吸収型製剤
US4910205A (en) Transdermal delivery of loratadine
PL175083B1 (pl) Przezskórny układ terapeutyczny do podawania galantaminy na skórę
DE10333393A1 (de) Transdermales Therapeutisches System mit dem Wirkstoff Pramipexol
JPWO2006090782A1 (ja) 含水系外用貼付剤用組成物及びこの組成物を用いた貼付剤
KR20100126830A (ko) 경피 흡수 제제
SK134395A3 (en) Transdermal therapeutical agent and preparation method thereof
DE4342174C1 (de) Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
EP1064939A2 (de) Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemetischen Behandlung
CA1309661C (en) Transdermal delivery system
EP1959938B1 (de) Matrixkontrolliertes transdermales system mit salzen der ace-hemmer-dicarbonsäuren
EP0306926A2 (en) Salbutamol-containing plaster and method of producing
EP1085858B1 (de) Transdermales therapeutisches system zur anwendung von candesartan
EP1368008B1 (de) Transdermales therapeutisches system zur verabreichung des partiellen dopamin-d2-agonisten aripiprazol
JPWO2017006974A1 (ja) 経皮吸収型貼付剤
DE60108870T2 (de) Transdermales Verabreichungssystem für die Behandlung von Harnwegserkrankungen
DE4229230C2 (de) Transdermales therapeutisches System mit Pentetrazol als Wirkstoff
KR100390870B1 (ko) 경피투여용 항구토제 조성물 및 이를 포함하는 제제
KR20040084783A (ko) 국소마취제를 함유하는 패취 제형
JPS63238017A (ja) 塩酸カルテオロ−ルを含有する水性外用貼付剤
DE10301930A1 (de) Verfahren zur medikamentösen therapeutischen oder prophylaktischen Behandlung
JP2016216384A (ja) 経皮吸収型製剤
KR20010005871A (ko) 경피흡수용 기제조성물 및 이 기제조성물을 함유하는 경피흡수제제